nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—neck—germ cell cancer	0.0168	0.0843	CbGeAlD
Rasagiline—CYP1A2—urine—germ cell cancer	0.0129	0.0644	CbGeAlD
Rasagiline—MAOB—ganglion—germ cell cancer	0.0123	0.0617	CbGeAlD
Rasagiline—BCL2—telencephalon—germ cell cancer	0.0114	0.0572	CbGeAlD
Rasagiline—BCL2—skin of body—germ cell cancer	0.0109	0.0546	CbGeAlD
Rasagiline—BCL2—gonad—germ cell cancer	0.00952	0.0477	CbGeAlD
Rasagiline—BCL2—uterus—germ cell cancer	0.00946	0.0474	CbGeAlD
Rasagiline—BCL2—bone marrow—germ cell cancer	0.00803	0.0402	CbGeAlD
Rasagiline—BCL2—female gonad—germ cell cancer	0.00774	0.0388	CbGeAlD
Rasagiline—BCL2—endocrine gland—germ cell cancer	0.00719	0.0361	CbGeAlD
Rasagiline—BCL2—head—germ cell cancer	0.0071	0.0356	CbGeAlD
Rasagiline—BCL2—testis—germ cell cancer	0.00686	0.0344	CbGeAlD
Rasagiline—MAOB—trigeminal ganglion—germ cell cancer	0.00605	0.0303	CbGeAlD
Rasagiline—MAOB—embryo—germ cell cancer	0.00584	0.0293	CbGeAlD
Rasagiline—MAOB—brainstem—germ cell cancer	0.00535	0.0268	CbGeAlD
Rasagiline—BCL2—brain—germ cell cancer	0.00515	0.0258	CbGeAlD
Rasagiline—BCL2—lymph node—germ cell cancer	0.00497	0.0249	CbGeAlD
Rasagiline—MAOB—telencephalon—germ cell cancer	0.00475	0.0238	CbGeAlD
Rasagiline—MAOB—decidua—germ cell cancer	0.0045	0.0226	CbGeAlD
Rasagiline—MAOB—uterus—germ cell cancer	0.00394	0.0197	CbGeAlD
Rasagiline—MAOB—pituitary gland—germ cell cancer	0.00387	0.0194	CbGeAlD
Rasagiline—MAOB—medulla oblongata—germ cell cancer	0.00373	0.0187	CbGeAlD
Rasagiline—MAOB—adrenal gland—germ cell cancer	0.00345	0.0173	CbGeAlD
Rasagiline—MAOB—midbrain—germ cell cancer	0.00341	0.0171	CbGeAlD
Rasagiline—MAOB—spinal cord—germ cell cancer	0.00333	0.0167	CbGeAlD
Rasagiline—MAOB—female gonad—germ cell cancer	0.00322	0.0161	CbGeAlD
Rasagiline—MAOB—endocrine gland—germ cell cancer	0.003	0.015	CbGeAlD
Rasagiline—MAOB—head—germ cell cancer	0.00296	0.0148	CbGeAlD
Rasagiline—MAOB—testis—germ cell cancer	0.00286	0.0143	CbGeAlD
Rasagiline—MAOB—cerebellum—germ cell cancer	0.00264	0.0132	CbGeAlD
Rasagiline—MAOB—brain—germ cell cancer	0.00214	0.0107	CbGeAlD
Rasagiline—CYP1A2—endocrine gland—germ cell cancer	0.00213	0.0107	CbGeAlD
Rasagiline—MAOB—lymph node—germ cell cancer	0.00207	0.0104	CbGeAlD
Rasagiline—Infection—Bleomycin—germ cell cancer	0.00142	0.00177	CcSEcCtD
Rasagiline—Feeling abnormal—Vinblastine—germ cell cancer	0.00139	0.00174	CcSEcCtD
Rasagiline—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00139	0.00173	CcSEcCtD
Rasagiline—Eye disorder—Cisplatin—germ cell cancer	0.00138	0.00173	CcSEcCtD
Rasagiline—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00138	0.00172	CcSEcCtD
Rasagiline—Anaemia—Ifosfamide—germ cell cancer	0.00138	0.00172	CcSEcCtD
Rasagiline—Cardiac disorder—Cisplatin—germ cell cancer	0.00137	0.00171	CcSEcCtD
Rasagiline—Agitation—Ifosfamide—germ cell cancer	0.00137	0.00171	CcSEcCtD
Rasagiline—Discomfort—Dactinomycin—germ cell cancer	0.00137	0.00171	CcSEcCtD
Rasagiline—Anorexia—Bleomycin—germ cell cancer	0.00136	0.0017	CcSEcCtD
Rasagiline—Thrombophlebitis—Methotrexate—germ cell cancer	0.00136	0.00169	CcSEcCtD
Rasagiline—Hypoaesthesia—Etoposide—germ cell cancer	0.00135	0.00168	CcSEcCtD
Rasagiline—Malaise—Ifosfamide—germ cell cancer	0.00135	0.00168	CcSEcCtD
Rasagiline—Vertigo—Ifosfamide—germ cell cancer	0.00134	0.00168	CcSEcCtD
Rasagiline—Urinary tract disorder—Etoposide—germ cell cancer	0.00134	0.00167	CcSEcCtD
Rasagiline—Leukopenia—Ifosfamide—germ cell cancer	0.00134	0.00167	CcSEcCtD
Rasagiline—Polyuria—Methotrexate—germ cell cancer	0.00134	0.00167	CcSEcCtD
Rasagiline—Immune system disorder—Cisplatin—germ cell cancer	0.00134	0.00167	CcSEcCtD
Rasagiline—Abdominal pain—Vinblastine—germ cell cancer	0.00133	0.00167	CcSEcCtD
Rasagiline—Mediastinal disorder—Cisplatin—germ cell cancer	0.00133	0.00167	CcSEcCtD
Rasagiline—Hypotension—Bleomycin—germ cell cancer	0.00133	0.00166	CcSEcCtD
Rasagiline—Urethral disorder—Etoposide—germ cell cancer	0.00133	0.00166	CcSEcCtD
Rasagiline—Infection—Dactinomycin—germ cell cancer	0.00132	0.00165	CcSEcCtD
Rasagiline—Alopecia—Cisplatin—germ cell cancer	0.00131	0.00163	CcSEcCtD
Rasagiline—Cough—Ifosfamide—germ cell cancer	0.0013	0.00163	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.0013	0.00162	CcSEcCtD
Rasagiline—Convulsion—Ifosfamide—germ cell cancer	0.00129	0.00162	CcSEcCtD
Rasagiline—Hypertension—Ifosfamide—germ cell cancer	0.00129	0.00161	CcSEcCtD
Rasagiline—Malnutrition—Cisplatin—germ cell cancer	0.00129	0.00161	CcSEcCtD
Rasagiline—Paraesthesia—Bleomycin—germ cell cancer	0.00128	0.0016	CcSEcCtD
Rasagiline—Dyspnoea—Bleomycin—germ cell cancer	0.00127	0.00159	CcSEcCtD
Rasagiline—Arthralgia—Ifosfamide—germ cell cancer	0.00127	0.00159	CcSEcCtD
Rasagiline—Chest pain—Ifosfamide—germ cell cancer	0.00127	0.00159	CcSEcCtD
Rasagiline—Renal failure acute—Methotrexate—germ cell cancer	0.00127	0.00159	CcSEcCtD
Rasagiline—Flatulence—Cisplatin—germ cell cancer	0.00127	0.00158	CcSEcCtD
Rasagiline—Anorexia—Dactinomycin—germ cell cancer	0.00127	0.00158	CcSEcCtD
Rasagiline—Eye disorder—Etoposide—germ cell cancer	0.00127	0.00158	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00126	0.00158	CcSEcCtD
Rasagiline—Cardiac disorder—Etoposide—germ cell cancer	0.00126	0.00157	CcSEcCtD
Rasagiline—Discomfort—Ifosfamide—germ cell cancer	0.00126	0.00157	CcSEcCtD
Rasagiline—Hypersensitivity—Vinblastine—germ cell cancer	0.00124	0.00155	CcSEcCtD
Rasagiline—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00124	0.00155	CcSEcCtD
Rasagiline—Decreased appetite—Bleomycin—germ cell cancer	0.00124	0.00155	CcSEcCtD
Rasagiline—Muscle spasms—Cisplatin—germ cell cancer	0.00124	0.00155	CcSEcCtD
Rasagiline—Angiopathy—Etoposide—germ cell cancer	0.00123	0.00154	CcSEcCtD
Rasagiline—Confusional state—Ifosfamide—germ cell cancer	0.00123	0.00154	CcSEcCtD
Rasagiline—Immune system disorder—Etoposide—germ cell cancer	0.00122	0.00153	CcSEcCtD
Rasagiline—Mediastinal disorder—Etoposide—germ cell cancer	0.00122	0.00153	CcSEcCtD
Rasagiline—Chills—Etoposide—germ cell cancer	0.00122	0.00152	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00121	0.00151	CcSEcCtD
Rasagiline—Asthenia—Vinblastine—germ cell cancer	0.00121	0.00151	CcSEcCtD
Rasagiline—Infection—Ifosfamide—germ cell cancer	0.00121	0.00151	CcSEcCtD
Rasagiline—Tremor—Cisplatin—germ cell cancer	0.00121	0.00151	CcSEcCtD
Rasagiline—Alopecia—Etoposide—germ cell cancer	0.0012	0.0015	CcSEcCtD
Rasagiline—Cerebrovascular accident—Methotrexate—germ cell cancer	0.0012	0.0015	CcSEcCtD
Rasagiline—Nervous system disorder—Ifosfamide—germ cell cancer	0.0012	0.00149	CcSEcCtD
Rasagiline—Ill-defined disorder—Cisplatin—germ cell cancer	0.00119	0.00149	CcSEcCtD
Rasagiline—Anaemia—Cisplatin—germ cell cancer	0.00119	0.00149	CcSEcCtD
Rasagiline—Skin disorder—Ifosfamide—germ cell cancer	0.00118	0.00148	CcSEcCtD
Rasagiline—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00118	0.00147	CcSEcCtD
Rasagiline—Feeling abnormal—Bleomycin—germ cell cancer	0.00118	0.00147	CcSEcCtD
Rasagiline—Osteoarthritis—Methotrexate—germ cell cancer	0.00117	0.00147	CcSEcCtD
Rasagiline—Anorexia—Ifosfamide—germ cell cancer	0.00116	0.00145	CcSEcCtD
Rasagiline—Malaise—Cisplatin—germ cell cancer	0.00116	0.00145	CcSEcCtD
Rasagiline—Decreased appetite—Dactinomycin—germ cell cancer	0.00116	0.00144	CcSEcCtD
Rasagiline—Diarrhoea—Vinblastine—germ cell cancer	0.00116	0.00144	CcSEcCtD
Rasagiline—Dysgeusia—Etoposide—germ cell cancer	0.00116	0.00144	CcSEcCtD
Rasagiline—Leukopenia—Cisplatin—germ cell cancer	0.00115	0.00144	CcSEcCtD
Rasagiline—Back pain—Etoposide—germ cell cancer	0.00114	0.00143	CcSEcCtD
Rasagiline—Hypotension—Ifosfamide—germ cell cancer	0.00114	0.00142	CcSEcCtD
Rasagiline—Muscle spasms—Etoposide—germ cell cancer	0.00113	0.00142	CcSEcCtD
Rasagiline—Urticaria—Bleomycin—germ cell cancer	0.00113	0.00142	CcSEcCtD
Rasagiline—Body temperature increased—Bleomycin—germ cell cancer	0.00113	0.00141	CcSEcCtD
Rasagiline—Dizziness—Vinblastine—germ cell cancer	0.00112	0.00139	CcSEcCtD
Rasagiline—Convulsion—Cisplatin—germ cell cancer	0.00112	0.00139	CcSEcCtD
Rasagiline—Mood swings—Methotrexate—germ cell cancer	0.00111	0.00139	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00111	0.00139	CcSEcCtD
Rasagiline—Ataxia—Methotrexate—germ cell cancer	0.0011	0.00138	CcSEcCtD
Rasagiline—Feeling abnormal—Dactinomycin—germ cell cancer	0.0011	0.00137	CcSEcCtD
Rasagiline—Paraesthesia—Ifosfamide—germ cell cancer	0.00109	0.00137	CcSEcCtD
Rasagiline—Ill-defined disorder—Etoposide—germ cell cancer	0.00109	0.00137	CcSEcCtD
Rasagiline—Anxiety—Cisplatin—germ cell cancer	0.00109	0.00136	CcSEcCtD
Rasagiline—Anaemia—Etoposide—germ cell cancer	0.00109	0.00136	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00109	0.00136	CcSEcCtD
Rasagiline—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00109	0.00136	CcSEcCtD
Rasagiline—Dyspnoea—Ifosfamide—germ cell cancer	0.00109	0.00136	CcSEcCtD
Rasagiline—Somnolence—Ifosfamide—germ cell cancer	0.00108	0.00135	CcSEcCtD
Rasagiline—Liver function test abnormal—Methotrexate—germ cell cancer	0.00108	0.00135	CcSEcCtD
Rasagiline—Discomfort—Cisplatin—germ cell cancer	0.00108	0.00135	CcSEcCtD
Rasagiline—Vomiting—Vinblastine—germ cell cancer	0.00107	0.00134	CcSEcCtD
Rasagiline—Malaise—Etoposide—germ cell cancer	0.00106	0.00133	CcSEcCtD
Rasagiline—Vertigo—Etoposide—germ cell cancer	0.00106	0.00132	CcSEcCtD
Rasagiline—Decreased appetite—Ifosfamide—germ cell cancer	0.00106	0.00132	CcSEcCtD
Rasagiline—Headache—Vinblastine—germ cell cancer	0.00106	0.00132	CcSEcCtD
Rasagiline—Leukopenia—Etoposide—germ cell cancer	0.00106	0.00132	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00105	0.00131	CcSEcCtD
Rasagiline—Abdominal pain—Dactinomycin—germ cell cancer	0.00105	0.00131	CcSEcCtD
Rasagiline—Body temperature increased—Dactinomycin—germ cell cancer	0.00105	0.00131	CcSEcCtD
Rasagiline—Hypersensitivity—Bleomycin—germ cell cancer	0.00105	0.00131	CcSEcCtD
Rasagiline—Infection—Cisplatin—germ cell cancer	0.00104	0.0013	CcSEcCtD
Rasagiline—Constipation—Ifosfamide—germ cell cancer	0.00104	0.0013	CcSEcCtD
Rasagiline—Loss of consciousness—Etoposide—germ cell cancer	0.00104	0.0013	CcSEcCtD
Rasagiline—Nervous system disorder—Cisplatin—germ cell cancer	0.00103	0.00129	CcSEcCtD
Rasagiline—Cough—Etoposide—germ cell cancer	0.00103	0.00129	CcSEcCtD
Rasagiline—Asthenia—Bleomycin—germ cell cancer	0.00102	0.00128	CcSEcCtD
Rasagiline—Convulsion—Etoposide—germ cell cancer	0.00102	0.00128	CcSEcCtD
Rasagiline—Skin disorder—Cisplatin—germ cell cancer	0.00102	0.00128	CcSEcCtD
Rasagiline—Hypertension—Etoposide—germ cell cancer	0.00102	0.00127	CcSEcCtD
Rasagiline—Hyperhidrosis—Cisplatin—germ cell cancer	0.00102	0.00127	CcSEcCtD
Rasagiline—Asthma—Methotrexate—germ cell cancer	0.00101	0.00127	CcSEcCtD
Rasagiline—Pruritus—Bleomycin—germ cell cancer	0.00101	0.00126	CcSEcCtD
Rasagiline—Feeling abnormal—Ifosfamide—germ cell cancer	0.001	0.00125	CcSEcCtD
Rasagiline—Chest pain—Etoposide—germ cell cancer	0.001	0.00125	CcSEcCtD
Rasagiline—Nausea—Vinblastine—germ cell cancer	0.001	0.00125	CcSEcCtD
Rasagiline—Anorexia—Cisplatin—germ cell cancer	0.001	0.00125	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000997	0.00125	CcSEcCtD
Rasagiline—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000997	0.00125	CcSEcCtD
Rasagiline—Discomfort—Etoposide—germ cell cancer	0.000992	0.00124	CcSEcCtD
Rasagiline—Hypotension—Cisplatin—germ cell cancer	0.000982	0.00123	CcSEcCtD
Rasagiline—Hypersensitivity—Dactinomycin—germ cell cancer	0.00098	0.00122	CcSEcCtD
Rasagiline—Confusional state—Etoposide—germ cell cancer	0.000971	0.00121	CcSEcCtD
Rasagiline—Urticaria—Ifosfamide—germ cell cancer	0.000968	0.00121	CcSEcCtD
Rasagiline—Abdominal pain—Ifosfamide—germ cell cancer	0.000964	0.0012	CcSEcCtD
Rasagiline—Body temperature increased—Ifosfamide—germ cell cancer	0.000964	0.0012	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000957	0.0012	CcSEcCtD
Rasagiline—Infection—Etoposide—germ cell cancer	0.000956	0.00119	CcSEcCtD
Rasagiline—Asthenia—Dactinomycin—germ cell cancer	0.000954	0.00119	CcSEcCtD
Rasagiline—Dysuria—Methotrexate—germ cell cancer	0.000948	0.00118	CcSEcCtD
Rasagiline—Paraesthesia—Cisplatin—germ cell cancer	0.000944	0.00118	CcSEcCtD
Rasagiline—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000942	0.00118	CcSEcCtD
Rasagiline—Dyspnoea—Cisplatin—germ cell cancer	0.000937	0.00117	CcSEcCtD
Rasagiline—Skin disorder—Etoposide—germ cell cancer	0.000935	0.00117	CcSEcCtD
Rasagiline—Erectile dysfunction—Methotrexate—germ cell cancer	0.000934	0.00117	CcSEcCtD
Rasagiline—Hyperhidrosis—Etoposide—germ cell cancer	0.000931	0.00116	CcSEcCtD
Rasagiline—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000926	0.00116	CcSEcCtD
Rasagiline—Anorexia—Etoposide—germ cell cancer	0.000918	0.00115	CcSEcCtD
Rasagiline—Decreased appetite—Cisplatin—germ cell cancer	0.000913	0.00114	CcSEcCtD
Rasagiline—Diarrhoea—Dactinomycin—germ cell cancer	0.00091	0.00114	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000907	0.00113	CcSEcCtD
Rasagiline—Vomiting—Bleomycin—germ cell cancer	0.000907	0.00113	CcSEcCtD
Rasagiline—Infestation—Methotrexate—germ cell cancer	0.000904	0.00113	CcSEcCtD
Rasagiline—Infestation NOS—Methotrexate—germ cell cancer	0.000904	0.00113	CcSEcCtD
Rasagiline—Depression—Methotrexate—germ cell cancer	0.000901	0.00113	CcSEcCtD
Rasagiline—Hypotension—Etoposide—germ cell cancer	0.0009	0.00112	CcSEcCtD
Rasagiline—Rash—Bleomycin—germ cell cancer	0.000899	0.00112	CcSEcCtD
Rasagiline—Dermatitis—Bleomycin—germ cell cancer	0.000898	0.00112	CcSEcCtD
Rasagiline—Hypersensitivity—Ifosfamide—germ cell cancer	0.000898	0.00112	CcSEcCtD
Rasagiline—Stomatitis—Methotrexate—germ cell cancer	0.000881	0.0011	CcSEcCtD
Rasagiline—Conjunctivitis—Methotrexate—germ cell cancer	0.000879	0.0011	CcSEcCtD
Rasagiline—Asthenia—Ifosfamide—germ cell cancer	0.000874	0.00109	CcSEcCtD
Rasagiline—Sweating—Methotrexate—germ cell cancer	0.000867	0.00108	CcSEcCtD
Rasagiline—Feeling abnormal—Cisplatin—germ cell cancer	0.000866	0.00108	CcSEcCtD
Rasagiline—Paraesthesia—Etoposide—germ cell cancer	0.000864	0.00108	CcSEcCtD
Rasagiline—Pruritus—Ifosfamide—germ cell cancer	0.000862	0.00108	CcSEcCtD
Rasagiline—Haematuria—Methotrexate—germ cell cancer	0.000862	0.00108	CcSEcCtD
Rasagiline—Dyspnoea—Etoposide—germ cell cancer	0.000858	0.00107	CcSEcCtD
Rasagiline—Somnolence—Etoposide—germ cell cancer	0.000856	0.00107	CcSEcCtD
Rasagiline—Epistaxis—Methotrexate—germ cell cancer	0.000853	0.00107	CcSEcCtD
Rasagiline—Nausea—Bleomycin—germ cell cancer	0.000847	0.00106	CcSEcCtD
Rasagiline—Vomiting—Dactinomycin—germ cell cancer	0.000846	0.00106	CcSEcCtD
Rasagiline—Rash—Dactinomycin—germ cell cancer	0.000839	0.00105	CcSEcCtD
Rasagiline—Decreased appetite—Etoposide—germ cell cancer	0.000837	0.00105	CcSEcCtD
Rasagiline—Diarrhoea—Ifosfamide—germ cell cancer	0.000834	0.00104	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000831	0.00104	CcSEcCtD
Rasagiline—Body temperature increased—Cisplatin—germ cell cancer	0.000831	0.00104	CcSEcCtD
Rasagiline—Constipation—Etoposide—germ cell cancer	0.000823	0.00103	CcSEcCtD
Rasagiline—Haemoglobin—Methotrexate—germ cell cancer	0.000816	0.00102	CcSEcCtD
Rasagiline—Haemorrhage—Methotrexate—germ cell cancer	0.000812	0.00101	CcSEcCtD
Rasagiline—Dizziness—Ifosfamide—germ cell cancer	0.000806	0.00101	CcSEcCtD
Rasagiline—Urinary tract disorder—Methotrexate—germ cell cancer	0.000802	0.001	CcSEcCtD
Rasagiline—Urethral disorder—Methotrexate—germ cell cancer	0.000796	0.000994	CcSEcCtD
Rasagiline—Feeling abnormal—Etoposide—germ cell cancer	0.000793	0.000991	CcSEcCtD
Rasagiline—Nausea—Dactinomycin—germ cell cancer	0.00079	0.000987	CcSEcCtD
Rasagiline—Gastrointestinal pain—Etoposide—germ cell cancer	0.000787	0.000983	CcSEcCtD
Rasagiline—Vomiting—Ifosfamide—germ cell cancer	0.000775	0.000968	CcSEcCtD
Rasagiline—Hypersensitivity—Cisplatin—germ cell cancer	0.000774	0.000967	CcSEcCtD
Rasagiline—Rash—Ifosfamide—germ cell cancer	0.000769	0.00096	CcSEcCtD
Rasagiline—Dermatitis—Ifosfamide—germ cell cancer	0.000768	0.000959	CcSEcCtD
Rasagiline—Urticaria—Etoposide—germ cell cancer	0.000765	0.000955	CcSEcCtD
Rasagiline—Body temperature increased—Etoposide—germ cell cancer	0.000761	0.000951	CcSEcCtD
Rasagiline—Abdominal pain—Etoposide—germ cell cancer	0.000761	0.000951	CcSEcCtD
Rasagiline—Eye disorder—Methotrexate—germ cell cancer	0.000758	0.000948	CcSEcCtD
Rasagiline—Asthenia—Cisplatin—germ cell cancer	0.000754	0.000942	CcSEcCtD
Rasagiline—Cardiac disorder—Methotrexate—germ cell cancer	0.000753	0.000941	CcSEcCtD
Rasagiline—Angiopathy—Methotrexate—germ cell cancer	0.000736	0.00092	CcSEcCtD
Rasagiline—Immune system disorder—Methotrexate—germ cell cancer	0.000733	0.000916	CcSEcCtD
Rasagiline—Mediastinal disorder—Methotrexate—germ cell cancer	0.000731	0.000914	CcSEcCtD
Rasagiline—Chills—Methotrexate—germ cell cancer	0.000728	0.00091	CcSEcCtD
Rasagiline—Nausea—Ifosfamide—germ cell cancer	0.000724	0.000904	CcSEcCtD
Rasagiline—Diarrhoea—Cisplatin—germ cell cancer	0.000719	0.000898	CcSEcCtD
Rasagiline—Alopecia—Methotrexate—germ cell cancer	0.000717	0.000896	CcSEcCtD
Rasagiline—Mental disorder—Methotrexate—germ cell cancer	0.000711	0.000888	CcSEcCtD
Rasagiline—Hypersensitivity—Etoposide—germ cell cancer	0.000709	0.000886	CcSEcCtD
Rasagiline—Malnutrition—Methotrexate—germ cell cancer	0.000707	0.000883	CcSEcCtD
Rasagiline—Dysgeusia—Methotrexate—germ cell cancer	0.000692	0.000864	CcSEcCtD
Rasagiline—Asthenia—Etoposide—germ cell cancer	0.000691	0.000863	CcSEcCtD
Rasagiline—Back pain—Methotrexate—germ cell cancer	0.000683	0.000854	CcSEcCtD
Rasagiline—Pruritus—Etoposide—germ cell cancer	0.000681	0.000851	CcSEcCtD
Rasagiline—Vomiting—Cisplatin—germ cell cancer	0.000668	0.000835	CcSEcCtD
Rasagiline—Rash—Cisplatin—germ cell cancer	0.000663	0.000828	CcSEcCtD
Rasagiline—Dermatitis—Cisplatin—germ cell cancer	0.000662	0.000827	CcSEcCtD
Rasagiline—Diarrhoea—Etoposide—germ cell cancer	0.000659	0.000823	CcSEcCtD
Rasagiline—Ill-defined disorder—Methotrexate—germ cell cancer	0.000656	0.000819	CcSEcCtD
Rasagiline—Anaemia—Methotrexate—germ cell cancer	0.000653	0.000816	CcSEcCtD
Rasagiline—Malaise—Methotrexate—germ cell cancer	0.000637	0.000796	CcSEcCtD
Rasagiline—Dizziness—Etoposide—germ cell cancer	0.000637	0.000795	CcSEcCtD
Rasagiline—Vertigo—Methotrexate—germ cell cancer	0.000635	0.000793	CcSEcCtD
Rasagiline—Leukopenia—Methotrexate—germ cell cancer	0.000632	0.00079	CcSEcCtD
Rasagiline—Nausea—Cisplatin—germ cell cancer	0.000624	0.00078	CcSEcCtD
Rasagiline—Cough—Methotrexate—germ cell cancer	0.000617	0.00077	CcSEcCtD
Rasagiline—Convulsion—Methotrexate—germ cell cancer	0.000612	0.000765	CcSEcCtD
Rasagiline—Vomiting—Etoposide—germ cell cancer	0.000612	0.000765	CcSEcCtD
Rasagiline—Rash—Etoposide—germ cell cancer	0.000607	0.000758	CcSEcCtD
Rasagiline—Dermatitis—Etoposide—germ cell cancer	0.000606	0.000758	CcSEcCtD
Rasagiline—Headache—Etoposide—germ cell cancer	0.000603	0.000753	CcSEcCtD
Rasagiline—Arthralgia—Methotrexate—germ cell cancer	0.000601	0.000751	CcSEcCtD
Rasagiline—Chest pain—Methotrexate—germ cell cancer	0.000601	0.000751	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000597	0.000746	CcSEcCtD
Rasagiline—Discomfort—Methotrexate—germ cell cancer	0.000594	0.000742	CcSEcCtD
Rasagiline—Confusional state—Methotrexate—germ cell cancer	0.000581	0.000726	CcSEcCtD
Rasagiline—Infection—Methotrexate—germ cell cancer	0.000573	0.000716	CcSEcCtD
Rasagiline—Nausea—Etoposide—germ cell cancer	0.000572	0.000714	CcSEcCtD
Rasagiline—Nervous system disorder—Methotrexate—germ cell cancer	0.000565	0.000706	CcSEcCtD
Rasagiline—Skin disorder—Methotrexate—germ cell cancer	0.00056	0.0007	CcSEcCtD
Rasagiline—Hyperhidrosis—Methotrexate—germ cell cancer	0.000557	0.000696	CcSEcCtD
Rasagiline—Anorexia—Methotrexate—germ cell cancer	0.00055	0.000687	CcSEcCtD
Rasagiline—Hypotension—Methotrexate—germ cell cancer	0.000539	0.000673	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000525	0.000656	CcSEcCtD
Rasagiline—Insomnia—Methotrexate—germ cell cancer	0.000522	0.000652	CcSEcCtD
Rasagiline—Paraesthesia—Methotrexate—germ cell cancer	0.000518	0.000647	CcSEcCtD
Rasagiline—Dyspnoea—Methotrexate—germ cell cancer	0.000514	0.000642	CcSEcCtD
Rasagiline—Somnolence—Methotrexate—germ cell cancer	0.000513	0.00064	CcSEcCtD
Rasagiline—Dyspepsia—Methotrexate—germ cell cancer	0.000508	0.000634	CcSEcCtD
Rasagiline—Decreased appetite—Methotrexate—germ cell cancer	0.000501	0.000626	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000498	0.000622	CcSEcCtD
Rasagiline—Feeling abnormal—Methotrexate—germ cell cancer	0.000475	0.000594	CcSEcCtD
Rasagiline—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000472	0.000589	CcSEcCtD
Rasagiline—Urticaria—Methotrexate—germ cell cancer	0.000458	0.000572	CcSEcCtD
Rasagiline—Abdominal pain—Methotrexate—germ cell cancer	0.000456	0.000569	CcSEcCtD
Rasagiline—Body temperature increased—Methotrexate—germ cell cancer	0.000456	0.000569	CcSEcCtD
Rasagiline—Hypersensitivity—Methotrexate—germ cell cancer	0.000425	0.000531	CcSEcCtD
Rasagiline—Asthenia—Methotrexate—germ cell cancer	0.000414	0.000517	CcSEcCtD
Rasagiline—Pruritus—Methotrexate—germ cell cancer	0.000408	0.00051	CcSEcCtD
Rasagiline—Diarrhoea—Methotrexate—germ cell cancer	0.000395	0.000493	CcSEcCtD
Rasagiline—Dizziness—Methotrexate—germ cell cancer	0.000381	0.000476	CcSEcCtD
Rasagiline—Vomiting—Methotrexate—germ cell cancer	0.000367	0.000458	CcSEcCtD
Rasagiline—Rash—Methotrexate—germ cell cancer	0.000364	0.000454	CcSEcCtD
Rasagiline—Dermatitis—Methotrexate—germ cell cancer	0.000363	0.000454	CcSEcCtD
Rasagiline—Headache—Methotrexate—germ cell cancer	0.000361	0.000451	CcSEcCtD
Rasagiline—Nausea—Methotrexate—germ cell cancer	0.000342	0.000428	CcSEcCtD
